Hematology (Amsterdam, Netherlands)

Keyphrases

Publications

volume 29, number 1, 2024

Yi-Gang Guo, Lu-Lu Zhang, Ping Hu, Zhang-Zhi Li, Rui-Bo Zhang, Xi Lv, Qiong Yi, Ling-Bo Zhan, Xue-Lian Feng
Correlation analysis of bone marrow microvessel density and miRNA expression on drug resistance in patients with chronic myelogenous leukemia after tyrosine kinase inhibitor treatment. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Peiming Li, Xueru Ma, Guofei Huang
Understanding thrombosis: the critical role of oxidative stress. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Feng Chen, Xiaoqing Dai, Azhong Li, Yinhong Zheng, Wei Hu
Quality assessment of the preparation and storage of leukocyte-depleted pooled platelet concentrates. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Zhaozhi Jiang, Tingting Liu, Youhong Wang, Jiao Li, Lusheng Guo
Effect of lncRNA XIST on acute myeloid leukemia cells via miR-142-5p-PFKP axis. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Azusa Nagao, Ayumi Deguchi, Keiji Nogami
Real-world long-term safety and effectiveness of turoctocog alfa in the treatment of haemophilia A in Japan: results from a multicentre, non-interventional, post-marketing study. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Zhaozhi Jiang, Tingting Liu, Youhong Wang, Jiao Li, Lusheng Guo
Effect of lncRNA XIST on acute myeloid leukemia cells via miR-142-5p-PFKP axis. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Christopher Puli'uvea, Tracey Immanuel, Taryn N Green, Peter Tsai, Peter R Shepherd, Maggie L Kalev-Zylinska
Insights into the role of JAK2-I724T variant in myeloproliferative neoplasms from a unique cohort of New Zealand patients. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Huimin Chen, Ruixue Ma, Qianqian Zhang, Fengyi Lu, Yuhan Ma, Jingxin Zhou, Jiang Cao, Kunming Qi, Zhiling Yan, Wei Sang, Feng Zhu, Haiying Sun, Depeng Li, Zhenyu Li, Hai Cheng, Kailin Xu, Wei Chen
The prognostic significance of POD24 in peripheral T-cell lymphoma. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Mihee Kim, Seo-Yeon Ahn, TaeHyung Kim, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, Ju Heon Park, Myung-Geun Shin, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim
Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Hans J Salwender, Niels Weinhold, Axel Benner, Kaya Miah, Maximilian Merz, Mathias Haenel, Christian Jehn, Elias Mai, Ekaterina Menis, Igor Blau, Christof Scheid, Dirk Hose, Anja Seckinger, Steffen Luntz, Britta Besemer, Markus Munder, Peter Brossart, Bertram Glass, Hans-Walter Lindemann, Katja Weisel, Christine Hanoun, Paul Schnitzler, Sarah Klemm, Hartmut Goldschmidt, Marc Raab, Ahmet Elmaagacli
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Lina Z Rüsing, Nicolas Kozakowski, Georg Jeryczynski, Lea Vospernik, Julia Riedl, Thomas Reiter, Heinz Gisslinger, Hermine Agis, Maria-Theresa Krauth
Renal outcome in multiple myeloma patients with cast nephropathy: a retrospective analysis of potential predictive values on clinical and renal outcome. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Yingzi Zhen, Di Ai, Kun Huang, Gang Li, Zhenping Chen, Runhui Wu
The influence of dead space in blood sampling needle on FVIII level and pharmacokinetic profiles in children with hemophilia. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Jie Ding, Yang Su, Yinglu Ruan, Nan Li, Qianchao Meng, Jiabang Yang, Li Chen, Chi Liu
Clinical features and outcomes of patients with acute myeloid leukemia: the single-center experience of 668 patients in China. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Miodrag Vučić, Jelena Milenkovic, Boris J Djindjic, Vladana Stojiljković, Dijana Stojanović, Branka Djordjevic, Maja Milojkovic, Sanja Velickovic
Indicators of stress hematopoiesis in the blood predict COVID-19 progression in patients over 65 years old. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Dong-Lin Liu, Yan-Jie Wang, Si-Yu Qian, Shan-Shan Ma, Meng-Jie Ding, Meng Dong, Jie-Ming Zhang, Ming-Zhi Zhang, Qing-Jiang Chen, Xu-Dong Zhang
Clinical features and prognosis of chronic natural killer cell lymphoproliferative disorders. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Linquan Zhan, Dai Yuan, Xueling Ge, Mei Ding, Jianhong Wang, Xiangxiang Zhou, Xin Wang
Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Linquan Zhan, Dai Yuan, Xueling Ge, Mei Ding, Jianhong Wang, Xiangxiang Zhou, Xin Wang
Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Zenghui Fang, Jiali Fu, Xin Chen
A combined immune and exosome-related risk signature as prognostic biomakers in acute myeloid leukemia. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Moisés Manuel Gallardo-Pérez, César Homero Gutiérrez-Aguirre, Juan Carlos Olivares-Gazca, Guillermo José Ruiz-Arguelles
More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses? Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Zhiqiang Xu, Jieni Yu, Yamei Chen
Hub genes and associated drugs for multiple myeloma with 1q21+: identified by bioinformatic analysis. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Marc Trossaërt, Aletta Falk, Laurène Gautier, Nana Kragh, Olivia Van Hinloopen, Remi Varin
An observational study of haemophilia A patients without inhibitors using the French national claims (SNDS) database. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Hans J Salwender, Niels Weinhold, Axel Benner, Kaya Miah, Maximilian Merz, Mathias Haenel, Christian Jehn, Elias Mai, Ekaterina Menis, Igor Blau, Christof Scheid, Dirk Hose, Anja Seckinger, Steffen Luntz, Britta Besemer, Markus Munder, Peter Brossart, Bertram Glass, Hans-Walter Lindemann, Katja Weisel, Christine Hanoun, Paul Schnitzler, Sarah Klemm, Hartmut Goldschmidt, Marc Raab, Ahmet Elmaagacli
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Marc Trossaërt, Aletta Falk, Laurène Gautier, Nana Kragh, Olivia Van Hinloopen, Remi Varin
An observational study of haemophilia A patients without inhibitors using the French national claims (SNDS) database. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Miodrag Vučić, Jelena Milenkovic, Boris J Djindjic, Vladana Stojiljković, Dijana Stojanović, Branka Djordjevic, Maja Milojkovic, Sanja Velickovic
Indicators of stress hematopoiesis in the blood predict COVID-19 progression in patients over 65 years old. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Azusa Nagao, Ayumi Deguchi, Keiji Nogami
Real-world long-term safety and effectiveness of turoctocog alfa in the treatment of haemophilia A in Japan: results from a multicentre, non-interventional, post-marketing study. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Jie Ding, Yang Su, Yinglu Ruan, Nan Li, Qianchao Meng, Jiabang Yang, Li Chen, Chi Liu
Clinical features and outcomes of patients with acute myeloid leukemia: the single-center experience of 668 patients in China. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Yingzi Zhen, Di Ai, Kun Huang, Gang Li, Zhenping Chen, Runhui Wu
The influence of dead space in blood sampling needle on FVIII level and pharmacokinetic profiles in children with hemophilia. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Lina Z Rüsing, Nicolas Kozakowski, Georg Jeryczynski, Lea Vospernik, Julia Riedl, Thomas Reiter, Heinz Gisslinger, Hermine Agis, Maria-Theresa Krauth
Renal outcome in multiple myeloma patients with cast nephropathy: a retrospective analysis of potential predictive values on clinical and renal outcome. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Dong-Lin Liu, Yan-Jie Wang, Si-Yu Qian, Shan-Shan Ma, Meng-Jie Ding, Meng Dong, Jie-Ming Zhang, Ming-Zhi Zhang, Qing-Jiang Chen, Xu-Dong Zhang
Clinical features and prognosis of chronic natural killer cell lymphoproliferative disorders. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Moisés Manuel Gallardo-Pérez, César Homero Gutiérrez-Aguirre, Juan Carlos Olivares-Gazca, Guillermo José Ruiz-Arguelles
More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses? Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Zhaozhi Jiang, Tingting Liu, Youhong Wang, Jiao Li, Lusheng Guo
Effect of lncRNA XIST on acute myeloid leukemia cells via miR-142-5p-PFKP axis. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Miodrag Vučić, Jelena Milenkovic, Boris J Djindjic, Vladana Stojiljković, Dijana Stojanović, Branka Djordjevic, Maja Milojkovic, Sanja Velickovic
Indicators of stress hematopoiesis in the blood predict COVID-19 progression in patients over 65 years old. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Yi-Gang Guo, Lu-Lu Zhang, Ping Hu, Zhang-Zhi Li, Rui-Bo Zhang, Xi Lv, Qiong Yi, Ling-Bo Zhan, Xue-Lian Feng
Correlation analysis of bone marrow microvessel density and miRNA expression on drug resistance in patients with chronic myelogenous leukemia after tyrosine kinase inhibitor treatment. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Jing Chen, Yi Zhao
Pre-treatment [ 18 F]FDG PET/CT for assessing bone marrow involvement and prognosis in patients with newly diagnosed peripheral T-cell lymphoma. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Kateřina Žibřidová, Ondřej Souček, Lenka Kujovska Krcmova, Karolína Jankovičová, Markéta Gančarčíková, Mária Anna Pejková, Jan Drugda, Denisa Nováková, Milan Košťál
Lymphocyte subpopulations: a potential predictor of a response in patients with immune thrombocytopenia. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Huimin Chen, Ruixue Ma, Qianqian Zhang, Fengyi Lu, Yuhan Ma, Jingxin Zhou, Jiang Cao, Kunming Qi, Zhiling Yan, Wei Sang, Feng Zhu, Haiying Sun, Depeng Li, Zhenyu Li, Hai Cheng, Kailin Xu, Wei Chen
The prognostic significance of POD24 in peripheral T-cell lymphoma. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Christopher Puli'uvea, Tracey Immanuel, Taryn N Green, Peter Tsai, Peter R Shepherd, Maggie L Kalev-Zylinska
Insights into the role of JAK2-I724T variant in myeloproliferative neoplasms from a unique cohort of New Zealand patients. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Kateřina Žibřidová, Ondřej Souček, Lenka Kujovska Krcmova, Karolína Jankovičová, Markéta Gančarčíková, Mária Anna Pejková, Jan Drugda, Denisa Nováková, Milan Košťál
Lymphocyte subpopulations: a potential predictor of a response in patients with immune thrombocytopenia. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Peiming Li, Xueru Ma, Guofei Huang
Understanding thrombosis: the critical role of oxidative stress. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Feng Chen, Xiaoqing Dai, Azhong Li, Yinhong Zheng, Wei Hu
Quality assessment of the preparation and storage of leukocyte-depleted pooled platelet concentrates. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Zenghui Fang, Jiali Fu, Xin Chen
A combined immune and exosome-related risk signature as prognostic biomakers in acute myeloid leukemia. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Liwei Fan, Runfeng Ni, Haijin Wang, Le Zhang, Aidi Wang, Baoshan Liu
Dioscin alleviates aplastic anemia through regulatory T cells promotion. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Mihee Kim, Seo-Yeon Ahn, TaeHyung Kim, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, Ju Heon Park, Myung-Geun Shin, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim
Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Zhiqiang Xu, Jieni Yu, Yamei Chen
Hub genes and associated drugs for multiple myeloma with 1q21+: identified by bioinformatic analysis. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Liwei Fan, Runfeng Ni, Haijin Wang, Le Zhang, Aidi Wang, Baoshan Liu
Dioscin alleviates aplastic anemia through regulatory T cells promotion. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Ying Chen, Zhe Chen, Junjie Cao, Li Lin, Jipeng Li
Severe and continuous immunoparesis during induction or maintenance therapy in nontransplant patients with multiple myeloma is a sign of poor prognosis. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Jing Chen, Yi Zhao
Pre-treatment [ 18 F]FDG PET/CT for assessing bone marrow involvement and prognosis in patients with newly diagnosed peripheral T-cell lymphoma. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Yingzi Zhen, Di Ai, Kun Huang, Gang Li, Zhenping Chen, Runhui Wu
The influence of dead space in blood sampling needle on FVIII level and pharmacokinetic profiles in children with hemophilia. Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Moisés Manuel Gallardo-Pérez, César Homero Gutiérrez-Aguirre, Juan Carlos Olivares-Gazca, Guillermo José Ruiz-Arguelles
More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses? Hematology (Amsterdam, Netherlands) 29 (1) (2024)
Moisés Manuel Gallardo-Pérez, César Homero Gutiérrez-Aguirre, Juan Carlos Olivares-Gazca, Guillermo José Ruiz-Arguelles
More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses? Hematology (Amsterdam, Netherlands) 29 (1) (2024)